Dr Raajit Chanana | Medical Oncologist in | Book Appointment
No Image

Dr Raajit Chanana

  • Medical Oncologist
  • Breast Cancer
  • 5 Years of Experience
  • Priority Appointment
  • Delhi
  • MBBS, MD (Internal Medicine), DM (Medical Oncology)

1000

Consultation

Medical Registration Verified

About Us

  • Dr. Raajit Chanana, Consultant Р Medical Oncology based in Delhi. He has an experience of 5 years in this field. He has completed his DM - Oncology from Tata Memorial Hospital, Mumbai in 2017, MD - Internal Medicine from University of Delhi in 2014 and MBBS from University of Delhi in 2010. He is European Certified Medical Oncologist. He is credited with many publications in national and international journals and has participated in clinical trials.

Show More

Information

Priority Appointment

Delhi

Common questions & answers

  • Who is Dr Raajit Chanana ?
  • Dr Raajit Chanana is a Medical Oncologist with experience of 5 years. Dr Raajit Chanana 's educational qualifications include MBBS, MD (Internal Medicine), DM (Medical Oncology) Dr Raajit Chanana. is a member of Delhi Medical Council (DMC) Medical Council of India (MCI) Indian Society of Medical and Paediatric Oncology (ISMPO) European Society of Medical Oncology (ESMO) American Society of Clinical Oncology (ASCO) . Dr Raajit Chanana's areas of interest include Breast Cancer, Stomach cancer
  • Where does Dr Raajit Chanana practice?
  • Dr Raajit Chanana practices at Priority Appointment
  • Why do patients visit Dr Raajit Chanana?
  • Patients frequently visit Dr Raajit Chanana for Breast Cancer, Stomach cancer
  • What is Dr Raajit Chanana's rating?
  • Dr Raajit Chanana is a highly rated Medical Oncologist with positive feedback from most patients treated.
  • What is Dr Raajit Chanana's education qualification?
  • Dr Raajit Chanana has the following qualifications: MBBS from Maulana Azad Medical College, Delhi University in December 2009 MD (Internal Medicine) from Lady Harding Medical College, Delhi University in April 2014 DM (Medical Oncology) from Tata Memorial Hospital, Mumbai in July 2017 ECMO (European Certified Medical Oncologist) in 2017
  • What does Dr Raajit Chanana specialize in?
  • Dr Raajit Chanana specializes as a Medical Oncologist with special interest in Breast Cancer, Stomach cancer .
  • How many years of experience does Dr Raajit Chanana have?
  • Dr Raajit Chanana has an overall experience of 5 years as a Medical Oncologist.
  • How can I book an appointment with Dr Raajit Chanana?
  • You can book an appointment with Dr Raajit Chanana by clicking "Book Appointment" on top-right. We shall shortly confirm your booking upon receiving your request.

Education

  • MBBS from Maulana Azad Medical College, Delhi University in December 2009 MD (Internal Medicine) from Lady Harding Medical College, Delhi University in April 2014 DM (Medical Oncology) from Tata Memorial Hospital, Mumbai in July 2017 ECMO (European Certified Medical Oncologist) in 2017

Paper & Presentations

  • Results of a phase II randomized controlled clinical trial comparing efficacy of cabazitaxel versus docetaxel as second-line or above therapy inrecurrent head and neck cancer. Amit Joshi, Vijay Maruti Patil, Vanita Noronha, Sachin Dhumal, Arun Chandrasekharan, Nikhil Pande, Chandrakanth MV, Vikas Talreja, DilipVallathol, Sujay Srinivas, RaajitChanana, Kushal Gupta, Sangeetha Parthiban, Kumar Prabhash: ASCO 2017 Annual Meeting.
  • A Retrospective Cohort Study to Evaluate the Outcomes of Multiple Myeloma Treated in a Tertiary Care Centre from India. RaajitChanana, Manju Sengar, Hasmukh Jain, NavinKhattry, BhausahebBagal, Deepa Philip, Sachin Punatar, Anant Gokarn. Menon Hari, Mangesh Kadam, PreetiPawaskar. International Myeloma Conference 2017.
  • Differential Efficacy of Gefitinib in Exon 19 or Exon 21 Mutated Adenocarcinoma Lung Topic: EGFR Biomarkers Alok Goel, Amit Joshi, Vijay Patil, Vanita Noronha, Anuradha Chougule, Abhishek Mahajan, Amit Janu, Rajiv Kaushal, Supriya Goud, Sucheta More, AshayKarpe, Anant Ramaswamy, Nikhil Pande, Arun Chandrasekharan, Vikas Talreja, RaajitChanana,,Kumar Prabhash. World Lung Conference 2016.
  • QOL Analysis of a phase II randomized controlled clinical trial comparing efficacy of Cabazitxel versus Docetaxel as second line or above in recurrent and metastatic head and neck cancer. R. Chanana, V. Noronha, A. Joshi, V. Patil, S. Dhumal , A. Bhattacharya 4 , A. Chandrasekharan, N. Pande, V.T. Talreja, S. Turkar 1 , S. Shrirangwar 1 , K.Prabhash. ESMO Asia 2017 P.
  • A Randomized Phase III study of gefitinib or Combination chemotherapy in EGFR mutated advanced lung adenocarcinoma, Vijay Maruti Patil, Vanita Noronha, Amit Joshi, Anuradha Bharat Choughule, Atanu Bhattacharjee, Rajiv Kumar, Supriya Goud, Sucheta More, Anant Ramaswamy, AshayKarpe, Nikhil Pande, Arun Chandrasekharan, Alok Goel, Vikas Talreja, Abhishek Mahajan, Amit Janu, NilenduPurandare, RaajitChanana,KumarPrabhash. Lung Cancer Update Mumbai 2017.
  • Treatment outcomes of Advanced Malignant Pleural Mesothelioma treated in a tertiary care centre. RaajitChanana, Vanita Noronha, Amit Joshi, Vijay Patil, Dipti Nakti, Kumar Prabhash. ICON 2018-Kochi.
  • A retrospective cohort study to evaluate the epidemiology and treatment outcomes of Advanced Malignant Pleural Mesothelioma treated with in a tertiary care centre from India. RaajitChanana, Vanita Noronha, Amit Joshi, Vijay Patil, Dipti Nakti, Kumar Prabhash. JSMO-2018.Kobe-Japan.

Memberships

  • Delhi Medical Council (DMC)
  • Medical Council of India (MCI)
  • Indian Society of Medical and Paediatric Oncology (ISMPO)
  • European Society of Medical Oncology (ESMO)
  • American Society of Clinical Oncology (ASCO)

Experience

  • Consultant ,Medical Oncology at Dharamshila Narayana Superspeciality Hospital

Areas of interest

  • Breast Cancer, Stomach cancer

General Availability

Mon Tue Wed Thu Fri Sat Sun
Pr 12pm - - - - - - -
12pm - 3pm - - - - - - -
After 5pm - - - - - - -

Reliability assured with certified labs


Select Address

Select Patient